Cardinal Health, Inc. Stock

Equities

CAH

US14149Y1082

Pharmaceuticals

Market Closed - Nyse 04:00:02 2024-05-24 pm EDT 5-day change 1st Jan Change
96.39 USD +0.35% Intraday chart for Cardinal Health, Inc. -2.71% -4.38%
Sales 2024 * 226B Sales 2025 * 210B Capitalization 23.48B
Net income 2024 * 955M Net income 2025 * 1.45B EV / Sales 2024 * 0.11 x
Net Debt 2024 * 732M Net Debt 2025 * 520M EV / Sales 2025 * 0.11 x
P/E ratio 2024 *
24.5 x
P/E ratio 2025 *
15.4 x
Employees 47,520
Yield 2024 *
2.09%
Yield 2025 *
2.12%
Free-Float 74.15%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.35%
1 week-2.71%
Current month-6.45%
1 month-6.91%
3 months-10.82%
6 months-9.30%
Current year-4.38%
More quotes
1 week
95.50
Extreme 95.5
99.28
1 month
95.50
Extreme 95.5
106.68
Current year
95.50
Extreme 95.5
116.04
1 year
80.90
Extreme 80.9
116.04
3 years
45.85
Extreme 45.85
116.04
5 years
39.05
Extreme 39.0508
116.04
10 years
39.05
Extreme 39.0508
116.04
More quotes
Managers TitleAgeSince
Chief Executive Officer 51 20-04-26
Director of Finance/CFO 53 23-02-09
Chief Tech/Sci/R&D Officer 54 20-12-31
Members of the board TitleAgeSince
Director/Board Member 55 22-09-05
Director/Board Member 71 13-09-11
Chairman 71 06-12-31
More insiders
Date Price Change Volume
24-05-24 96.39 +0.35% 1,206,966
24-05-23 96.05 -0.28% 2,058,950
24-05-22 96.32 +0.32% 1,814,371
24-05-21 96.01 -2.49% 2,178,653
24-05-20 98.46 -0.63% 1,399,894

Delayed Quote Nyse, May 24, 2024 at 04:00 pm EDT

More quotes
Cardinal Health, Inc. is specialized in the distribution of products and health services to pharmacies, hospitals and medical practices. Net sales break down by activity as follows: - distribution of pharmaceutical products (92.7%); - distribution of medical, surgical and laboratory products (7.3%). The group also develops a manufacturing of medical and surgical products activity (masks, overalls, gloves, diagnostic products, products of aspiration and collection of liquids, radiology intervention, respiratory assistance, etc.). The United States accounts for 97.7% of net sales.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
96.39 USD
Average target price
111.8 USD
Spread / Average Target
+15.97%
Consensus